Patient Safety Organizations: Voluntary Relinquishment for the Women's Health USA Patient Safety Organization PSO, 53897 [2023-17002]
Download as PDF
Federal Register / Vol. 88, No. 152 / Wednesday, August 9, 2023 / Notices
involves the acquisition of a nonbanking
company, the review also includes
whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843) and interested persons
may express their views in writing on
the standards enumerated in section 4.
Unless otherwise noted, nonbanking
activities will be conducted throughout
the United States.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than September 8, 2023.
A. Federal Reserve Bank of Dallas
(Karen Smith, Director, Mergers &
Acquisitions) 2200 North Pearl Street,
Dallas, Texas 75201–2272. Comments
can also be sent electronically to
Comments.applications@dal.frb.org:
1. Homeland Bancshares, Inc.,
Columbia, Louisiana; to become a bank
holding company by acquiring Peoples
Bank, Chatham, Louisiana, and also to
retain Homeland Federal Savings Bank,
Columbia, Louisiana, and Beauregard
Federal Savings Bank, DeRidder,
Louisiana, and thereby engage in
operating a savings association pursuant
to section 225.28(b)(4)(ii) of the Board’s
Regulation Y.
A. Federal Reserve Bank of Kansas
City (Jeffrey Imgarten, Assistant Vice
President) One Memorial Drive, Kansas
City, Missouri 64198–0001. Comments
can also be sent electronically to
KCApplicationComments@kc.frb.org:
1. Savile Capital Group LLC,
Sheridan, Wyoming; to become a bank
holding company by acquiring Farmers
State Bankshares, Inc., and thereby
indirectly acquiring Wyoming Bank &
Trust, both of Cheyenne, Wyoming.
Board of Governors of the Federal Reserve
System.
Margaret McCloskey Shanks,
Deputy Secretary of the Board.
[FR Doc. 2023–17090 Filed 8–8–23; 8:45 am]
lotter on DSK11XQN23PROD with NOTICES1
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Relinquishment for the
Women’s Health USA Patient Safety
Organization PSO
Agency for Healthcare Research
and Quality (AHRQ), Department of
Health and Human Services (HHS).
ACTION: Notice of delisting.
AGENCY:
The Patient Safety and
Quality Improvement Final Rule
(Patient Safety Rule) authorizes AHRQ,
on behalf of the Secretary of HHS, to list
as a patient safety organization (PSO) an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found to no longer
meet the requirements of the Patient
Safety and Quality Improvement Act of
2005 (Patient Safety Act) and Patient
Safety Rule, when a PSO chooses to
voluntarily relinquish its status as a
PSO for any reason, or when a PSO’s
listing expires. AHRQ accepted a
notification of proposed voluntary
relinquishment from the Women’s
Health USA Patient Safety Organization
PSO, PSO number P0207, of its status as
a PSO, and has delisted the PSO
accordingly.
SUMMARY:
The delisting was effective at
12:00 Midnight ET (2400) on July 21,
2023.
DATES:
The directories for both
listed and delisted PSOs are ongoing
and reviewed weekly by AHRQ. Both
directories can be accessed
electronically at the following HHS
website: https://www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT:
Cathryn Bach, Center for Quality
Improvement and Patient Safety, AHRQ,
5600 Fishers Lane, MS 06N100B,
Rockville, MD 20857; Telephone (toll
free): (866) 403–3697; Telephone (local):
(301) 427–1111; TTY (toll free): (866)
438–7231; TTY (local): (301) 427–1130;
Email: pso@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
Background
The Patient Safety Act, 42 U.S.C.
299b-21 to 299b-26, and the related
Patient Safety Rule, 42 CFR part 3,
published in the Federal Register on
November 21, 2008 (73 FR 70732–
70814), establish a framework by which
individuals and entities that meet the
definition of provider in the Patient
Safety Rule may voluntarily report
VerDate Sep<11>2014
18:19 Aug 08, 2023
Jkt 259001
PO 00000
Frm 00040
Fmt 4703
Sfmt 9990
53897
information to PSOs listed by AHRQ, on
a privileged and confidential basis, for
the aggregation and analysis of patient
safety work product.
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity are to
conduct activities to improve patient
safety and the quality of health care
delivery.
HHS issued the Patient Safety Rule to
implement the Patient Safety Act.
AHRQ administers the provisions of the
Patient Safety Act and Patient Safety
Rule relating to the listing and operation
of PSOs. The Patient Safety Rule
authorizes AHRQ to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ if
it is found to no longer meet the
requirements of the Patient Safety Act
and Patient Safety Rule, when a PSO
chooses to voluntarily relinquish its
status as a PSO for any reason, or when
a PSO’s listing expires. Section 3.108(d)
of the Patient Safety Rule requires
AHRQ to provide public notice when it
removes an organization from the list of
PSOs.
AHRQ has accepted a notification of
proposed voluntary relinquishment
from the Women’s Health USA Patient
Safety Organization PSO to voluntarily
relinquish its status as a PSO.
Accordingly, the Women’s Health USA
Patient Safety Organization PSO, P0207,
was delisted effective at 12:00 Midnight
ET (2400) on July 21, 2023.
Women’s Health USA Patient Safety
Organization PSO has patient safety
work product (PSWP) in its possession.
The PSO will meet the requirements of
section 3.108(c)(2)(i) of the Patient
Safety Rule regarding notification to
providers that have reported to the PSO
and of section 3.108(c)(2)(ii) regarding
disposition of PSWP consistent with
section 3.108(b)(3). According to section
3.108(b)(3) of the Patient Safety Rule,
the PSO has 90 days from the effective
date of delisting and revocation to
complete the disposition of PSWP that
is currently in the PSO’s possession.
More information on PSOs can be
obtained through AHRQ’s PSO website
at https://www.pso.ahrq.gov.
Dated: August 3, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023–17002 Filed 8–8–23; 8:45 am]
BILLING CODE 4160–90–P
E:\FR\FM\09AUN1.SGM
09AUN1
Agencies
[Federal Register Volume 88, Number 152 (Wednesday, August 9, 2023)]
[Notices]
[Page 53897]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-17002]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Patient Safety Organizations: Voluntary Relinquishment for the
Women's Health USA Patient Safety Organization PSO
AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department
of Health and Human Services (HHS).
ACTION: Notice of delisting.
-----------------------------------------------------------------------
SUMMARY: The Patient Safety and Quality Improvement Final Rule (Patient
Safety Rule) authorizes AHRQ, on behalf of the Secretary of HHS, to
list as a patient safety organization (PSO) an entity that attests that
it meets the statutory and regulatory requirements for listing. A PSO
can be ``delisted'' by the Secretary if it is found to no longer meet
the requirements of the Patient Safety and Quality Improvement Act of
2005 (Patient Safety Act) and Patient Safety Rule, when a PSO chooses
to voluntarily relinquish its status as a PSO for any reason, or when a
PSO's listing expires. AHRQ accepted a notification of proposed
voluntary relinquishment from the Women's Health USA Patient Safety
Organization PSO, PSO number P0207, of its status as a PSO, and has
delisted the PSO accordingly.
DATES: The delisting was effective at 12:00 Midnight ET (2400) on July
21, 2023.
ADDRESSES: The directories for both listed and delisted PSOs are
ongoing and reviewed weekly by AHRQ. Both directories can be accessed
electronically at the following HHS website: https://www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT: Cathryn Bach, Center for Quality
Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, MS 06N100B,
Rockville, MD 20857; Telephone (toll free): (866) 403-3697; Telephone
(local): (301) 427-1111; TTY (toll free): (866) 438-7231; TTY (local):
(301) 427-1130; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act, 42 U.S.C. 299b-21 to 299b-26, and the
related Patient Safety Rule, 42 CFR part 3, published in the Federal
Register on November 21, 2008 (73 FR 70732-70814), establish a
framework by which individuals and entities that meet the definition of
provider in the Patient Safety Rule may voluntarily report information
to PSOs listed by AHRQ, on a privileged and confidential basis, for the
aggregation and analysis of patient safety work product.
The Patient Safety Act authorizes the listing of PSOs, which are
entities or component organizations whose mission and primary activity
are to conduct activities to improve patient safety and the quality of
health care delivery.
HHS issued the Patient Safety Rule to implement the Patient Safety
Act. AHRQ administers the provisions of the Patient Safety Act and
Patient Safety Rule relating to the listing and operation of PSOs. The
Patient Safety Rule authorizes AHRQ to list as a PSO an entity that
attests that it meets the statutory and regulatory requirements for
listing. A PSO can be ``delisted'' if it is found to no longer meet the
requirements of the Patient Safety Act and Patient Safety Rule, when a
PSO chooses to voluntarily relinquish its status as a PSO for any
reason, or when a PSO's listing expires. Section 3.108(d) of the
Patient Safety Rule requires AHRQ to provide public notice when it
removes an organization from the list of PSOs.
AHRQ has accepted a notification of proposed voluntary
relinquishment from the Women's Health USA Patient Safety Organization
PSO to voluntarily relinquish its status as a PSO. Accordingly, the
Women's Health USA Patient Safety Organization PSO, P0207, was delisted
effective at 12:00 Midnight ET (2400) on July 21, 2023.
Women's Health USA Patient Safety Organization PSO has patient
safety work product (PSWP) in its possession. The PSO will meet the
requirements of section 3.108(c)(2)(i) of the Patient Safety Rule
regarding notification to providers that have reported to the PSO and
of section 3.108(c)(2)(ii) regarding disposition of PSWP consistent
with section 3.108(b)(3). According to section 3.108(b)(3) of the
Patient Safety Rule, the PSO has 90 days from the effective date of
delisting and revocation to complete the disposition of PSWP that is
currently in the PSO's possession.
More information on PSOs can be obtained through AHRQ's PSO website
at https://www.pso.ahrq.gov.
Dated: August 3, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023-17002 Filed 8-8-23; 8:45 am]
BILLING CODE 4160-90-P